According to the latest data from the Hong Kong Stock Exchange, on February 2, Lazard Asset Management LLC purchased an additional 1,163,040 shares of SINOPHARM (01099) at a price of HK$20.699 per share. The total value of the transaction was approximately HK$24.07 million. Following this acquisition, the firm's total shareholding has reached about 148 million shares, representing a stake of 11.06%.